1. Market Research
  2. > Healthcare Market Trends
Interventional Radiology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Interventional Radiology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • November 2021
  • 139 pages
  • ID: 6184954
  • Format: PDF
  • Mordor Intelligence LLP

Summary

Table of Contents

Search Inside

The global interventional radiology market is projected to register a CAGR of 6.47% during the forecast period, with a revenue of USD 21,261.62 million in 2020 and expected to reach USD 31,262.67 million by 2026

The COVID-19 outbreak showed the impact on the interventional radiology market, as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals, globally.

In August 2020, a research was published in the SAGE Public Health Emergency Collection. where the researchers studied the overall impact of the COVID-19 pandemic on interventional radiology services in Canada. The study found out that there was a 49.3% overall decrease in demand for acute interventional radiology services across Canada. About 88% of respondents in the study also reported an overall decrease in elective interventional radiology services during the pandemic. A similar scanrio can be observed in other countries tackling COVID-19 related issues in 2020, which impact this market.

The driving factors of the market are rising trend of minimally-invasive procedures, owing to the cost-effective solution and lesser hospital stay. With the help of minimally invasive techniques, patients are treated quickly and are usually discharged from the hospital on the same day. Most of these processeses require imaging technology.

Innovation in imaging technologies, which provides real-time images to the surgeons to show a comprehensive view of internal organs, while diagnosing, is driving the interventional radiology market. One major field of advancement is in augmented reality and artificial intelligence. In contrast to virtual reality, where the field of vision for doctors includes no real images, augmented reality offers the ability to move objects (scopes and devices) inside the body and interact with its surroundings. This dynamic development has a variety of applications for image-led interventions. Artificial intelligence uses complex algorithms to detect abnormalities and anomalies in medical images, like CT scans and X-rays.

Chronic diseases persist, often for illnesses or chronic conditions, such as heart disease, asthma, cancer, and diabetes. Heart disease is the leading cause of death, worldwide. Cardiovascular diseases are the major causes of death, globally. Until years ago, treatment for heart disease meant opening a patient’s chest to enter directly into the heart, with surgery, which was very expensive and often exposed the patient to a high risk of infection.

According to GLOBOCAN 2020 figures, in 2019, there were 19,292,729 new cancer cases diagnosed, worldwide. The figures from GLOBOCAN 2020 pointed out that the incidence of new cancer cases in very high HDI (Human Development Index) countries was 8.9 million, followed by 7.4 million in high HDI countries. Medium and low HDI countries had 2.3 million and 0.7 million cases, respectively. The high incidence of cancer cases in countries with higher standards of living is primarily due to the availability and access to better diagnostic procedures. Interventional radiology equipment, like CT scanners and MRI systems, are used extensively for these procedures, due to which their demand is expected to increase

The increasing preference for minimally-invasive procedures and the prevalence of chronic diseases are driving the interventional radiology market. The market is expected to grow steadily, owing to effective interventional procedures performed in lieu of surgery.

Key Market Trends

Application in Cardiology is Expected to Witness the High Growth over the Forecast Period

The pandemic had its effect even on the cardiology segment. In May 2020, an article appearing in the Journal of the American College of Radiology studied the changes in interventional radiology procedures during the COVID-19 pandemic. The study found out that the number of interventional radiology procedures performed during the COVID-19 pandemic decreased from 1,710 to 919 (in a one-month period), constituting a 46% reduction compared to 2019. The study also found out that among CT-guided procedures, there was a 90% reduction in bone and central nervous system-related procedures.

Interventional radiology involves the use of medical imaging to see inside the body coupled with minimally invasive techniques to diagnose and treat cancer, as well as provide relief from symptoms. Surgeons and doctors use tools such as catheters and needles to address a large variety of medical conditions that would have required surgery in the past. The most common diseases treated with this technique include cancers of the lung, liver, kidney, and bone. But this is a growing field, and researchers are exploring its use in treating a variety of other cancer types.

Moreover, the incidence of cardiovascular disorders in recent years has increased. According to the Centers for Disease Control and Prevention, one person in every 36 seconds died in United States due to cardiovascular diseases every year, accounting to 655,000 Americans deaths from heart disease every year.

According to the research article published in the Journal of the American Heart Association, in 2019, 48 institutions in the United States were offering advanced cardiac imaging fellowship training, which includes training on cardiac computed tomography, cardiac magnetic resonance imaging, echocardiography, and nuclear cardiology. This shows the growing importance of cardiac imaging across developed countries.

In December 2020, RSIP Vision launched a new artificial intelligence ultrasound module for rapid and accurate point of care heart evaluations. The company are steadily expected to regain full strength in th market over the forecast period.

Thus, in view of the increasing incidences of cardiovascular diseases and new product launches, the studied market is expected to witness good growth over the forecast period.

North America to Expected to Dominate the Market Over the Forecast Period

The growing burden of chronic diseases, due to changing lifestyles and the growing need for less expensive interventions, leading to the study market, in the United States. Cardiac catheterization is widely used, to diagnose and treat various heart diseases. More than a million cardiac catheterizations and angiographic procedures are performed annually, in the United States.

Several radiology interventions can be used to treat cancer patients. For example, transarterial chemoembolization can interrupt blood supply to a tumor, while radiofrequency ablation (RFA) and microwave ablation can damage cancer cells themselves. According to the National Cancer Institute, in 2018, an estimated 1,735,350 young people with cancer are expected to be diagnosed in the United States, and 609,640 people are likely to die from the disease.

In addition, new product developments and launches are expected to fuel the Canadian market growth over the forecast period. For instance, in May 2020, Guerbet, one of the global companies in medical imaging, announces the registration of Vectorio kit for imaging of hepatocellular carcinoma (HCC), in Canada. Vectorio is a set of Lipiodol resistant medical devices for imaging of liver tumors in adults with known hepatocellular carcinoma during interventional oncology procedures.

The rising prevalence of chronic conditions, such as cancer, diabetes, and others, and the prospects of minimally-invasive, targeted treatments, using imaging guidance, are driving the market in the United States.

Competitive Landscape

The interventional radiology market is highly competitive and consists of global as well as local players, across the world. Some of the companies that currently dominate the market include GE Healthcare, Fujifilm Holdings Corporation, Koninklijke Philips NV, Siemens AG, and Shimadzu Corporation, among others. However, with technological advancements, it is expected that few small and mid-sized companies will also penetrate the market, in the future.

Additional Benefits:

The market estimate (ME) sheet in Excel format
3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Medical Isolation Gowns Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ; Product Type ; End User, and Geography

  • $ 4550
  • November 2021
  • 184 pages

The global medical isolation gowns market is expected to reach US$ 3,542.78 million by 2028 from US$ 1,346.31 million in 2021; it is estimated to grow at a CAGR of 14.8% from 2021 to 2028. Key factors ...

  • World
  • Europe
  • Healthcare
  • Infectious Disease
  • Industry analysis
  • Health Expenditure
  • Cause-Specific Mortality Rate

ref:plp2021

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on